Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 4/20 | 0.47 |
| ▸ | DRD3 | P35462 | 4/20 | 0.47 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.43 |
| ▸ | DRD4 | P21917 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5860445 | 1.00 | — | — | |
| SCHEMBL8860654 | 1.00 | DRD2 (0.47) | DRD2DRD3PIK3CDMEN1KMT2A | |
| SCHEMBL13833151 | 1.00 | DRD2 (0.47) | DRD2DRD3PIK3CDMEN1KMT2A | |
| SCHEMBL17996818 | 1.00 | DRD2 (0.47) | DRD2DRD3PIK3CDMEN1KMT2A | |
| SCHEMBL3970694 | 1.00 | DRD2 (0.47) | DRD2DRD3PIK3CDMEN1KMT2A | |
| SCHEMBL24688086 | 0.92 | MEN1 (0.50) | DRD2DRD3PIK3CDMEN1KMT2A | |
| SCHEMBL17996819 | 0.92 | MEN1 (0.50) | DRD2DRD3PIK3CDMEN1KMT2A | |
| SCHEMBL4650626 | 0.92 | DRD2 (0.44) | DRD2DRD3PIK3CDMEN1KMT2A | |
| SCHEMBL14906559 | 0.92 | PIK3CD (0.56) | DRD2DRD3PIK3CDMEN1KMT2A | |
| SCHEMBL17968369 | 0.92 | MEN1 (0.50) | DRD2DRD3PIK3CDMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 424 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037116-A | Combined polyether, polyurethane composition, polyurethane foam, preparation method of polyurethane foam and refrigeration equipment | TCL家用电器（合肥）有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4720149-A1 | AMINE CATALYSTS FOR POLYURETHANE APPLICATIONS | Evonik Operations GmbH (DE) | 2026-04-08 | — | — | EP | claimed |
| CN-119455647-A | Multifunctional composite material for synergistic purification of multiple pollutants and preparation method thereof | 浙江海亮环境材料有限公司 | 2025-02-18 | — | — | CN | claimed |
| WO-2024245991-A1 | AMINE CATALYSTS FOR POLYURETHANE APPLICATIONS | EVONIK OPERATIONS GMBH (DE) | 2024-12-05 | — | — | WO | claimed |
| EP-3484982-B1 | POLYESTER DISPERSANTS, SYNTHESIS AND USE THEREOF | CHEVRON ORONITE CO (US) | 2024-05-22 | — | — | EP | claimed |
| CN-114062091-B | Method for detecting hydroxyalkyl piperazine in flue gas desulfurizing agent | 安徽大学 | 2023-09-01 | — | — | CN | claimed |
| CN-109153934-B | Polyester dispersants, synthesis and uses thereof | 雪佛龙奥伦耐有限责任公司 | 2022-04-05 | — | — | CN | claimed |
| US-10421832-B2 | Low emissions polyurethane foam made with isocyanate reactive amine catalysts | EVONIK DEGUSSA GMBH (DE) | 2019-09-24 | — | — | US | claimed |
| EP-2726201-B1 | REDUCING EMISSIONS IN POLYURETHANE FOAM | EVONIK DEGUSSA GMBH (DE) | 2019-05-08 | — | — | EP | claimed |
| US-10030099-B2 | Digestion of keratin | RESINATE MATERIALS GROUP, INC. (US) | 2018-07-24 | — | — | US | claimed |
| EP-1337234-A1 | USE OF 2-OXOTHIAZOLIDINE 4-CARBOXYLIC ACID DERIVATIVES AS AGENTS PROMOTING SKIN PEELING | L'OREAL (FR) | 2003-08-27 | — | — | EP | claimed |
| EP-1337233-A1 | USE OF AT LEAST A SULPHONIC AMINO DERIVATIVE IN A COMPOSITION PROMOTING SKIN PEELING | L'OREAL (FR) | 2003-08-27 | — | — | EP | claimed |
| US-20020128421-A1 | Curable compositions | SHELVEY MICHAEL FRANCIS (GB) | 2002-09-12 | — | — | US | claimed |
| EP-0850256-B1 | CURABLE COMPOSITIONS | BSN MEDICAL INC (US) | 2002-07-17 | — | — | EP | claimed |
| WO-2002039975-A1 | USE OF AT LEAST A SULPHONIC AMINO DERIVATIVE IN A COMPOSITION PROMOTING SKIN PEELING | L'OREAL (FR) | 2002-05-23 | — | — | WO | claimed |
| WO-2002039976-A1 | USE OF 2-OXOTHIAZOLIDINE 4-CARBOXYLIC ACID DERIVATIVES AS AGENTS PROMOTING SKIN PEELING | L'OREAL (FR) | 2002-05-23 | — | — | WO | claimed |
| US-20010005744-A1 | CURABLE COMPOSITIONS | BSN MEDICAL, INC. | 2001-06-28 | — | — | US | claimed |
| US-5709737-A | AQUEOUS LIQUID VEHICLE, COLORANT, ALCOHOL ADDITIVE; SUITABLE FOR MICROWAVE DRYING PROCESSES | XEROX CORPORATION (US) | 1998-01-20 | — | — | US | claimed |
| US-4187112-A | Photosensitive plate containing nitrogen containing condensation type polyesters | TOYOBO CO., LTD. (JP) | 1980-02-05 | — | — | US | claimed |
| US-3956329-A | CRACKING CYCLIZATION | SHUNAN PETROCHEMICAL COMPANY, LTD. (JA) | 1976-05-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10030099-B2 | Digestion of keratin | KRT18, UNG, PNMT | DRD2 3421/4885DRD3 3928/4885PIK3CD 4183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.